Evaluation of the Effect of the Training Program Based on the Precede-Proceed Model on Guality Life Style

July 19, 2023 updated by: Ayşenur SARIASLAN, Ataturk University

Evaluation of the Effect of the Training Program Based on the Precede-Proceed Model on Adherence to Treatment and Healthy Lifestyle Behaviors of Hemodialysis Patients

This study was conducted to evaluate the effect of a Precede-Proceed Model-based (PPM-based) training program on treatment adherence, healthy lifestyle behaviors, and quality of life of hemodialysis patients.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The Precede proceed model includes structured training phases to bring positive behavior change. The model, which consists of training phases, provides the researcher with the opportunity to identify the problem and the deficiencies that cause the problem, evaluate the quality of life with these deficiencies and develop a health program for its solution. In order to apply the nine-phase model, the individual-patient's voluntary cooperation, determination and active participation in health practices are required.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yakutiye
      • Erzurum, Yakutiye, Turkey
        • Ataturk University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18 years of age or older,
  • Hemodialysis treatment for at least 6 months,
  • A total score of 1 or more from the Dialysis Diet and Fluid Restriction Non-Compliance Scale,
  • A score between 1 and 7 on the scale of compliance with medical treatment,
  • Place, time, person orientation,
  • Does not have a psychiatric illness or a problem that prevents written or verbal communication,

Exclusion Criteria:

  • Diagnosed with psychiatric illness Individuals with a diagnosis of malignancy wanting to leave research
  • Those who do not attend all of the trainings / do not want to continue
  • Individuals whose general condition is deteriorated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Using the experimental group as a result of the training based on PPM

The training sessions planned within the scope of PPM were applied to the patients, who were divided into groups of six according to the bed order, for 15-20 minutes for eight weeks, when the patients felt well, through training booklets and power point presentations. When the trainings started, the posters prepared were hung in the waiting room while the intervention group was undergoing hemodialysis. The person providing the care of the patient was included in each training. During the trainings, it was requested that the training booklets be with the patients and the power point presentations continued in parallel with the training booklets.

  • Post-test was applied to intervention group
  • three months after the post-test application, follow-up test was applied to the intervention group in order to evaluate the impact.
The training program based on the precede proceed model was applied to hemodialysis patients for 8 sessions. Eight sessions of training were given to the experimental group within the scope of the model, a booklet was developed in line with the trainings and posters were prepared.
No Intervention: Using the control group as a result of the training based on PPM
After the follow-up test, training was given to the patients in the control group and a model-based training booklet was distributed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the Effect of the Training Program based on the Precede-Proceed Model on quality of life style of Hemodialysis Patients
Time Frame: six month
The patients' quality of life was evaluated with the SF-12 Quality of Life scale. The scale consists of 12 items. There is no breakpoint. The higher the score obtained from the scale, the higher the quality of life.
six month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
2. Evaluation of the Effects of the Continuation Test (follow-up test results 3 months after the post-test) and the Education Program Based on the Pre-Continuation Model on the Quality of Life of Hemodialysis Patients
Time Frame: three month
The patients' quality of life was evaluated with the SF-12 Quality of Life scale. The scale consists of 12 items. There is no breakpoint. The higher the score obtained from the scale, the higher the quality of life.
three month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 18, 2021

Primary Completion (Actual)

December 8, 2022

Study Completion (Actual)

December 8, 2022

Study Registration Dates

First Submitted

June 1, 2023

First Submitted That Met QC Criteria

July 19, 2023

First Posted (Actual)

July 21, 2023

Study Record Updates

Last Update Posted (Actual)

July 21, 2023

Last Update Submitted That Met QC Criteria

July 19, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis Patient

Clinical Trials on ppm based training

3
Subscribe